These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9811524)

  • 1. Clearance of murine leukaemia virus from monoclonal antibody solution by a hydrophilic PVDF microporous membrane filter.
    Aranha-Creado H; Peterson J; Huang PY
    Biologicals; 1998 Jun; 26(2):167-72. PubMed ID: 9811524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane filtration for virus removal.
    Brandwein H; Aranha-Creado H
    Dev Biol (Basel); 2000; 102():157-63. PubMed ID: 10794103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of a microporous polyvinylidene fluoride (PVDF) membrane filter to separate contaminating viral particles from biologically important proteins.
    Oshima KH; Evans-Strickfaden TT; Highsmith AK; Ades EW
    Biologicals; 1996 Jun; 24(2):137-45. PubMed ID: 8889061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real time quantitative PCR as a method to evaluate xenotropic murine leukemia virus removal during pharmaceutical protein purification.
    Shi L; Chen Q; Norling LA; Lau AS; Krejci S; Xu Y
    Biotechnol Bioeng; 2004 Sep; 87(7):884-96. PubMed ID: 15334415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limits in virus filtration capability? Impact of virus quality and spike level on virus removal with xenotropic murine leukemia virus.
    Roush DJ; Myrold A; Burnham MS; And JV; Hughes JV
    Biotechnol Prog; 2015; 31(1):135-44. PubMed ID: 25395156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of filtration properties of hepatitis B virus, hepatitis C virus and simian virus 40 using a polyvinylidene fluoride membrane filter.
    Oshima KH; Evans-Strickfaden T; Highsmith A
    Vox Sang; 1998; 75(3):181-8. PubMed ID: 9852404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of removal of human retroviruses.
    Marcus-Sekura CJ
    Dev Biol Stand; 1991; 75():133-43. PubMed ID: 1794615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virus filtration of high-concentration monoclonal antibody solutions.
    Marques BF; Roush DJ; Göklen KE
    Biotechnol Prog; 2009; 25(2):483-91. PubMed ID: 19353736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virus retention by a hydrophilic triple-layer PVDF microporous membrane filter.
    Aranha-Creado H; Oshima K; Jafari S; Howard G; Brandwein H
    PDA J Pharm Sci Technol; 1997; 51(3):119-24. PubMed ID: 9203825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of virus safety of an antihemophilc factor IX by virus filtration process.
    Kim IS; Choi YW; Kang Y; Sung HM; Sohn KW; Kim YS
    J Microbiol Biotechnol; 2008 Jul; 18(7):1317-25. PubMed ID: 18667862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of methods for the estimation of retroviral burden.
    Bierley ST; Raineri R; Poiley JA; Morgan EM
    Dev Biol Stand; 1996; 88():163-5. PubMed ID: 9119132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation and validation of virus removal by ultrafiltration during the production of diaspirin crosslinked haemoglobin (DCLHb).
    Azari M; Boose JA; Burhop KE; Camacho T; Catarello J; Darling A; Ebeling AA; Estep TN; Pearson L; Guzder S; Herren J; Ogle K; Paine J; Rohn K; Sarajari R; Sun CS; Zhang L
    Biologicals; 2000 Jun; 28(2):81-94. PubMed ID: 10885615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Process scale considerations in evaluation studies and scale-up.
    Walter JK; Werz W; Berthold W
    Dev Biol Stand; 1996; 88():99-108. PubMed ID: 9119169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cumulative viral titer reduction demonstrated by sequential challenge of a tangential flow membrane filtration system and a direct flow pleated filter cartridge.
    Aranha-Creado H; Fennington GJ
    PDA J Pharm Sci Technol; 1997; 51(5):208-12. PubMed ID: 9357307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved removal of viruslike particles from purified monoclonal antibody IgM preparation via virus filtration.
    Maerz H; Hahn SO; Maassen A; Meisel H; Roggenbuck D; Sato T; Tanzmann H; Emmrich F; Marx U
    Nat Biotechnol; 1996 May; 14(5):651-2. PubMed ID: 9630961
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficient removal of viruses by a novel polyvinylidene fluoride membrane filter.
    Roberts P
    J Virol Methods; 1997 Apr; 65(1):27-31. PubMed ID: 9128859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Removal of xenotropic murine leukemia virus by nanocellulose based filter paper.
    Asper M; Hanrieder T; Quellmalz A; Mihranyan A
    Biologicals; 2015 Nov; 43(6):452-6. PubMed ID: 26328471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Removal of TSE agents by depth or membrane filtration from plasma products.
    Roberts PL; Evans D; Harris L
    Biologicals; 2010 Jan; 38(1):158-61. PubMed ID: 19854662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of retroviral detection for rodent cell-derived products and gene therapy applications.
    Hughes JV; Messner K; Burnham M; Patel D; White EM
    Dev Biol Stand; 1996; 88():297-304. PubMed ID: 9119153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of viral removal by nanofiltration using real-time quantitative polymerase chain reaction.
    Zhao X; Bailey MR; Emery WR; Lambooy PK; Chen D
    Biotechnol Appl Biochem; 2007 Jun; 47(Pt 2):97-104. PubMed ID: 17233631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.